Search Results 5481-5490 of 17114 for mesenteric fat and ibd

1. A Study to Screen Mothers for Metabolic Problems and Compare Treatment with Alternative Vitamin/Mineral Supplement - Mayo Clinic

   The purpose of this study is to screen mothers of young children with Autism Spectrum Disorders for metabolic problems, and find if it can be treated with a ...

2. Association of Outcome and the Presence of Ultrasound-measured Pleural Effusion in the Liver Transplant Patient - Mayo Clinic

   The purpose of this study is to: To determine whether the presence of pleural effusion measured by bedside ultrasound in the immediate pre-liver transplant ...

3. A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations - Mayo Clinic

   A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous ...

4. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. A Study of the Prevalence of Probable and Diagnosed REM Sleep Behavior Disorder - Mayo Clinic

   The purpose of this study is to determine the frequency of sleep behavior disorder by age group and sex in Olmsted County MN. Participation eligibility.

6. Defibrotide for Patients with Hepatic Veno-occlusive Disease: A Treatment IND Study - Mayo Clinic

   Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...

7. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

   Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

8. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 - Mayo Clinic

   The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with ...

9. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

   The purpose of this trial is to confirm if benralizumab can reduce OCS dependence (after dose optimisation) in patients who are uncontrolled on high-dose ICS- ...

10. A Study of Pulmonary Vascular Disease Phenomics Program - Mayo Clinic

    This will include survival, clinical staging, clinical group assignment, 6-minute walk, echocardiography, and blood for a broad collection of selected OMICS ...